File S10136 ("Free COVID-19 antiviral drugs for all New Yorkers") is before the New York Legislature and has not been decided. Latest step (April 30, 2026): In Senate Committee.
New York file S10136, before the New York Legislature. Still to be decided as of 2026-04-30.
No copay or deductible for FDA-approved COVID antivirals If you have insurance in New York and a doctor prescribes an FDA-approved antiviral for COVID-19 treatment, you pay nothing out-of-pocket for that medication.
Insurance premiums may rise to cover medication costs Eliminating cost-sharing for these drugs shifts expenses to insurers, which typically pass increased costs to all enrollees through higher premiums or reduced coverage elsewhere.
Coverage depends on insurance type and federal funding status The bill may not apply to uninsured New Yorkers, self-funded employer plans exempt from state regulation, or if federal COVID emergency funds that currently cover antivirals expire before state implementation.
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Read the official record for S10136
See everything up for a vote · This week in New York · See what we have filed with the clerk